MARKET

MRNA

MRNA

Moderna
NASDAQ

Real-time Quotes | Nasdaq Last Sale

58.57
-3.02
-4.90%
After Hours: 58.90 +0.33 +0.56% 19:59 07/02 EDT
OPEN
60.00
PREV CLOSE
61.59
HIGH
61.80
LOW
55.81
VOLUME
26.54M
TURNOVER
--
52 WEEK HIGH
87.00
52 WEEK LOW
11.54
MARKET CAP
22.71B
P/E (TTM)
-38.9765
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average MRNA stock price target is 91.90 with a high estimate of 112.00 and a low estimate of 68.00.

EPS

MRNA News

More
Why Moderna Shares Climbed 228.3% in the First Half
Motley Fool · 6h ago
European stocks lifted by data, but U.S. holiday keeps a lid on action
marketwatch.com · 12h ago
INSIGHT-How Moderna execs are cashing in on COVID-19 vaccine stock speculation
Reuters · 1d ago
Report: Moderna COVID-19 Vaccine Trial Delayed
Motley Fool · 1d ago
COVID-19 vaccines to enter late-stage trial by end of July, Fauci says
Reuters · 1d ago
Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses
Reuters · 1d ago
Moderna Shares Off on Report Coronavirus Trial Delayed
TheStreet.com · 1d ago
Moderna On Reports Of Phase 3 Vaccine Trial Delay Says Still Expects To Begin In July And 'We Expect To Be The First To Start Phase 3 Trial'; Says Has Worked Closely With NIH/Operation Warp Speed To Align On Final Protocol In Order To Begin On Time
Benzinga · 1d ago

Industry

Biotechnology & Medical Research
+0.67%
Pharmaceuticals & Medical Research
+0.61%

Hot Stocks

Symbol
Price
%Change

About MRNA

Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize the potency of mRNA once in the target cells. It has advanced in parallel a diverse development pipeline of 21 programs, of which 10 have entered clinical studies and another three have open INDs. Its therapeutics and vaccine development programs span infectious diseases, oncology, cardiovascular diseases, and rare genetic diseases. It has created six modalities prophylactic vaccines, cancer vaccines, intratumoral immmuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics and systemic intracellular therapeutics.
More

Webull offers kinds of Moderna Inc stock information, including NASDAQ:MRNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRNA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRNA stock methods without spending real money on the virtual paper trading platform.